Cargando…
FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells
Multiply myeloma (MM) grows in and destroys bone, where osteocytes secrete FGF23, a hormone which affects phosphate homeostasis and aging. We report that multiple myeloma (MM) cells express receptors for and respond to FGF23. FGF23 increased mRNA for EGR1 and its target heparanase, a pro-osteolytic...
Autores principales: | Suvannasankha, Attaya, Tompkins, Douglas R., Edwards, Daniel F., Petyaykina, Katarina V., Crean, Colin D., Fournier, Pierrick G., Parker, Jamie M., Sandusky, George E., Ichikawa, Shoji, Imel, Erik A., Chirgwin, John M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637311/ https://www.ncbi.nlm.nih.gov/pubmed/25944690 |
Ejemplares similares
-
Role of bone-anabolic agents in the treatment of breast cancer bone metastases
por: Suvannasankha, Attaya, et al.
Publicado: (2014) -
The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis
por: Lontos, Konstantinos, et al.
Publicado: (2018) -
FGF23, Hypophosphatemia, and Emerging Treatments
por: Imel, Erik A, et al.
Publicado: (2019) -
Acquired Factor X Deficiency in Patients With Primary Light Chain Amyloidosis
por: Dejhansathit, Siroj, et al.
Publicado: (2019) -
Osteocyte Vegf-a contributes to myeloma-associated angiogenesis and is regulated by Fgf23
por: Mulcrone, Patrick L., et al.
Publicado: (2020)